RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas: Relationship between 1p/19q status and progression-free survival Article

cited authors

  • Vogelbaum, MA; Berkey, B; Peereboom, D; Giannini, C; Jenkins, R; Suh, J; Brown, P; Blumenthal, D; Biggs, C; Mehta, M

fiu authors

publication date

  • June 20, 2006

Digital Object Identifier (DOI)

start page

  • 1517

end page

  • 1517


  • 24


  • 18_suppl